SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-17-229492
Filing Date
2017-07-18
Accepted
2017-07-17 17:54:02
Documents
1
Group Members
CL ALASKA, L.P.CRESTLINE INVESTORS, INC.CRESTLINE MANAGEMENT, L.P.CRESTLINE SI (GP), L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d421060dsc13da.htm SC 13D/A 91255
  Complete submission text file 0001193125-17-229492.txt   92685
Mailing Address 201 MAIN STREET SUITE 1900 FORT WORTH TX 76102
Business Address
BRATTON DOUGLAS K (Filed by) CIK: 0001281933 (see all company filings)

Type: SC 13D/A

Mailing Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109
Business Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109 2065821600
Juno Therapeutics, Inc. (Subject) CIK: 0001594864 (see all company filings)

IRS No.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88476 | Film No.: 17968257
SIC: 2836 Biological Products, (No Diagnostic Substances)